IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q1 2016 Holdings

Filed 2016-05-16 | 20 holdings | $16.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2016-08-15) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Accuray Inc(ARAY)COM004397105$14.8M2,553,21887.4%
Biogen Inc(BIIB)COM09062X103$1.8M6,72310.4%
Accelerate Diagnostics IncACOM004304200$72.4K5,037,7470.4%
Quidel CorpCOM74838J101$44.4K2,573,5540.3%
Opko Health Inc(OPK)COM68375N103$40.7K3,914,0000.2%
Nxstage Medical IncCOM67072V103$40.4K2,694,6360.2%
Mazor Robotics LTDSPONSORED ADS57886P103$36.2K2,909,5660.2%
Tesaro IncCOM881569107$28.2K640,9660.2%
Pacific Biosciences Calif in(PACB)COM69404D108$26.6K3,312,0890.2%
Biolase IncCOM090911108$13.8K10,529,5250.1%
Intrexon CorpCOM46122T102$13.7K403,7290.1%
Vermillion IncCOM NEW92407M206$12.7K8,624,2250.1%
Hansen MedicalCOM411307101$11.7K4,491,8200.1%
Amarin Corp PLCSPONS ADR NEW023111206$8.9K5,818,8050.1%
Agenus IncCOM00847G101$7.8K1,882,4770.0%
Transition Therapeutics IncCOM NEW893716209$4.9K3,817,9720.0%
Contrafect Corp(CFRXEUR)COM212326102$4.0K1,182,0320.0%
Metabolix IncCOM591018809$1.4K726,9350.0%
Second Sight MED Prods IncCOM81362J100$24550,8040.0%
Ziopharm Oncology IncCOM98973P101$496,6610.0%